Page 15 - CAN-16-26153 - Cancer Institute 2015 Outcomes Report

Membership

NRG Oncology NRG Oncology seeks to improve the lives
of cancer patients by conducting practice-
NRG Oncology is a changing multi-institutional clinical and
non-profit research translational research with emphases on
organization formed gender-specific malignancies including
to conduct oncologic gynecologic, breast and prostate cancers
clinical research and to broadly disseminate and on localized or locally advanced
study results for informing clinical decision cancers of all types.
making and healthcare policy. It brings
together the National Surgical Adjuvant
Breast and Bowel Project (NSABP), the
Radiation Therapy Oncology Group
(RTOG), and the Gynecologic Oncology
Group (GOG) — each recognized
internationally as a research leader.

NRG Oncology embodies an impressive
legacy in the conduct of multi-institutional
Phase II and Phase III clinical trials and
a history of undertaking Phase I and
translational biological studies imperative
for oncologic research of the future.

2015 Outcomes Report 15